Skip to main content
AMP 2023 Annual Meeting & Expo Main banner
Final Program


Icon Legend
Presentation Icons
Platinum Award
Platinum Award
Gold Award
Gold Award
Silver Award
Silver Award
Bronze Award
Bronze Award

  1. Home

  • Thursday, Nov 16th
    10:15 AM - 11:45 AM MST
    Polygenic Risk Scores - Implementation and Clinical Utility
    Location: 255EF, Second Level
    Co-Moderator: Honey Reddi, PhD – Medical College of Wisconsin
    Co-Moderator: Meng-Chang Hsiao, PhD – Vanderbilt University Medical Center
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Thursday, Nov 16th
    10:15 AM - 10:45 AM MST
    Clinical Implementation of Polygenic Risk Scores
    Location: 255EF, Second Level
    Speaker: Aya Abu-El-Haija, MD MPH – Boston Children's Hospital
    Inherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Thursday, Nov 16th
    10:45 AM - 11:15 AM MST
    Implementation of Polygenic Risk Scores - Laboratory Perspectives
    Location: 255EF, Second Level
    Speaker: Matthew Lebo, PhD (he/him/his) – Lab for Molecular Medicine, Mass General Brigham Personalized Medicine
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Thursday, Nov 16th
    11:15 AM - 11:45 AM MST
    Status of the Use of Polygenic Scores for PGT
    Location: 255EF, Second Level
    Speaker: Patrick Turley, PhD (he/him/his) – University of Southern California
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Friday, Nov 17th
    10:55 AM - 11:15 AM MST
    Novel Diagnostic DNA Methylation Episignatures Expand and Refine the Epigenetic Landscapes of Mendelian Disorders
    Location: 255EF, Second Level
    Speaker: Bekim Sadikovic, PhD – London Health Sciences Centre, Western University, London, ON, Canada.
    Lab ManagementInherited ConditionsMolecular Methodologies & Technologies
     CE: NOT CME/CMLE
  • Friday, Nov 17th
    11:15 AM - 11:45 AM MST
    Panel Discussion
    Location: 255EF, Second Level
    Speaker: Michael E. Talkowski, PhD (he/him/his) – Center for Genomic Medicine of Massachusetts General Hospital, Harvard Medical School
    Speaker: Bekim Sadikovic, PhD – London Health Sciences Centre, Western University, London, ON, Canada.
    Speaker: Danny Miller, MD, PhD (he/him/his) – University of Washington
    Lab ManagementInherited ConditionsMolecular Methodologies & Technologies
     CE: NOT CME/CMLE
  • Friday, Nov 17th
    1:15 PM - 1:45 PM MST
    Newborn Screening by Genomic Sequencing: Opportunities and Challenges
    Location: 355BC, Third Level
    Speaker: Wendy Chung, MD, PhD (she/her/hers) – Boston Children's Hospital/Harvard Medical School
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Friday, Nov 17th
    1:45 PM - 2:15 PM MST
    Adding Genomic Sequencing and Genetic Risk Scores to the Early Check Newborn Screening Study
    Location: 355BC, Third Level
    Speaker: Katerina S. Kucera, PhD – RTI International
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Friday, Nov 17th
    2:15 PM - 2:45 PM MST
    Exploring Whole Genome Sequencing for Newborn Screening: Lessons from the BabySeq Project
    Location: 355BC, Third Level
    Speaker: Matthew Lebo, PhD (he/him/his) – Lab for Molecular Medicine, Mass General Brigham Personalized Medicine
    AdvocacyInherited ConditionsMolecular Methodologies & Technologies
     CE: 1.50
  • Saturday, Nov 18th
    8:15 AM - 9:15 AM MST
    DNA Hypomethylation Restrains Malignant Progression
    Location: Grand Ballroom, Lower Concourse
    Speaker: Sarah Johnstone, MD, PhD – Dana-Farber Cancer Institute
    OncologyInherited Conditions
     CE: 1.0
  • Saturday, Nov 18th
    1:15 PM - 1:45 PM MST
    AMP Working Group: Standardization of Pharmacogenomics Alleles
    Location: 250, Upper Concourse
    Speaker: Karen Weck, MD (she/her/hers) – University of North Carolina at Chapel Hill
    Lab ManagementInherited ConditionsMolecular Methodologies & Technologies
     CE: NOT CME/CMLE
  • Saturday, Nov 18th
    1:45 PM - 2:15 PM MST
    Panel Discussion: AMP Working Group: Standardization of Pharmacogenomics Alleles
    Location: 250, Upper Concourse
    Panelist: Karen Weck, MD (she/her/hers) – University of North Carolina at Chapel Hill
    Panelist: Lisa V. Kalman, PhD – Centers for Disease Control and Prevention
    Panelist: Stuart A. Scott, PhD – Stanford University
    Panelist: Houda Hachad, PharmD. M Res. (she/her/hers) – AccessDx Laboratory
    Lab ManagementInherited ConditionsMolecular Methodologies & Technologies
     CE: NOT CME/CMLE